U.S. markets closed

Broadridge Financial Solutions, Inc. (BR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
136.60+1.35 (+1.00%)
At close: 4:00PM EDT

137.97 +1.37 (1.00%)
After hours: 5:02PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close135.25
Open135.74
Bid136.64 x 800
Ask136.50 x 800
Day's Range135.30 - 137.05
52 Week Range81.90 - 137.84
Volume578,186
Avg. Volume648,039
Market Cap15.684B
Beta (5Y Monthly)0.88
PE Ratio (TTM)38.48
EPS (TTM)3.55
Earnings DateAug 11, 2020
Forward Dividend & Yield2.16 (1.60%)
Ex-Dividend DateJun 11, 2020
1y Target Est131.29
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-3% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Broadridge Financial Soln's Earnings: A Preview

    On Tuesday, August 11, Broadridge Financial Soln (NYSE: BR) will release its latest earnings report. Benzinga's outlook for Broadridge Financial Soln is included in the following report.Earnings and Revenue Wall Street expects EPS of $2.09 and sales around $1.32 billion. In the same quarter last year, Broadridge Financial Soln reported EPS of $1.72 on revenue of $1.21 billion. The Wall Street estimate would represent a 21.51% increase in the company's earnings. Here's how the company's reported EPS has stacked up against analyst estimates in the past:Quarter Q3 2020 Q2 2020 Q1 2019 Q4 2019 EPS Estimate 1.72 0.72 0.71 1.71 EPS Actual 1.67 0.53 0.68 1.72 Revenue Estimate 1.25 B 995.23 M 979.61 M 1.22 B Revenue Actual 1.25 B 968.70 M 948.60 M 1.21 B Stock Performance Over the last 52-week period, shares are up 6.93%. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release.View more earnings on BRDon't be surprised to see the stock move on comments made during its conference call. Broadridge Financial Soln is scheduled to hold the call at 11:00:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/c9h8im7gSee more from Benzinga * Stocks That Hit 52-Week Highs On Wednesday * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Barrons.com

    30,000 Volunteers Currently Participating in Covid-19 Vaccine Trials, and Two More Numbers to Know

    89% of the S&P 500’s market cap have already reported second-quarter results. Moderna, Pfizer, and AstraZeneca’s efforts to develop a Covid-19 vaccine enter Phase 3. And Apple splits its stock.